Covered recipient · General Payments record
JULIA P SPEROS
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2021–2024
$1,100.36
- Reported across 53 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $595.70 | 32 |
| Education | $142.87 | 3 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Biotech, Inc. | $209.57 | 6 |
| PFIZER INC. | $180.87 | 14 |
| ABBVIE INC. | $115.84 | 5 |
| GENZYME CORPORATION | $80.45 | 3 |
| Lilly USA, LLC | $48.73 | 2 |
| E.R. Squibb & Sons, L.L.C. | $35.75 | 1 |
| Regeneron Healthcare Solutions, Inc. | $21.61 | 1 |
| Galderma Laboratories, L.P. | $18.66 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $13.60 | 1 |
| Arcutis Biotherapeutics, Inc. | $13.49 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.50 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108238558 | CMS |
| ABBVIE INC. | $30.50 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108238560 | CMS |
| ABBVIE INC. | $17.08 | 07/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108238562 | CMS |
| ABBVIE INC. | $26.38 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108238564 | CMS |
| ABBVIE INC. | $24.38 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108238566 | CMS |
| Arcutis Biotherapeutics, Inc. | $13.49 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121102556 | CMS |
| E.R. Squibb & Sons, L.L.C. | $35.75 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101271683 | CMS |
| Galderma Laboratories, L.P. | $18.66 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145393911 | CMS |
| GENZYME CORPORATION | $14.36 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139784195 | CMS |
| GENZYME CORPORATION | $31.59 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139784201 | CMS |
| GENZYME CORPORATION | $34.50 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139784225 | CMS |
| Janssen Biotech, Inc. | $68.99 | 04/22/2024 | Education | Undisputed | 01/23/2026 | 1078544770 | CMS |
| Janssen Biotech, Inc. | $10.30 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078543941 | CMS |
| Janssen Biotech, Inc. | $11.26 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078542783 | CMS |
| Janssen Biotech, Inc. | $72.00 | 09/06/2024 | Education | Undisputed | 01/23/2026 | 1078543952 | CMS |
| Janssen Biotech, Inc. | $24.94 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078542679 | CMS |
| Janssen Biotech, Inc. | $22.08 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078544866 | CMS |
| Lilly USA, LLC | $23.69 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135730902 | CMS |
| Lilly USA, LLC | $25.04 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135728767 | CMS |
| Novartis Pharmaceuticals Corporation | $13.60 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087203695 | CMS |
| PFIZER INC. | $1.88 | 01/23/2024 | Education | Undisputed | 01/23/2026 | 1131605668 | CMS |
| PFIZER INC. | $14.76 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131109386 | CMS |
| PFIZER INC. | $14.76 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131128584 | CMS |
| PFIZER INC. | $14.76 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131270918 | CMS |
| PFIZER INC. | $14.76 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131480177 | CMS |
| PFIZER INC. | $0.50 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131919717 | CMS |
| PFIZER INC. | $14.76 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131686290 | CMS |
| PFIZER INC. | $14.76 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131754474 | CMS |
| PFIZER INC. | $16.13 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131771415 | CMS |
| PFIZER INC. | $14.76 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131864865 | CMS |
| PFIZER INC. | $14.76 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131950442 | CMS |
| PFIZER INC. | $14.76 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132109545 | CMS |
| PFIZER INC. | $14.76 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131165650 | CMS |
| PFIZER INC. | $14.76 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131165859 | CMS |
| Regeneron Healthcare Solutions, Inc. | $21.61 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114376279 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.